Trials / Unknown
UnknownNCT03363451
A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIR Study)
A Retrospective Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIR Study)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The term of End Stage of Liver Disease (ESLD) was raised in 80's of 20 Century, but without a restrict definition. Infections are the cause and effect in occurrence and development of ESLD, which not only induce or exacerbate ESLD, but also are the most combined complication. Multi-resistant bacteria, multi-organ injury, selection of anti-microbes, supporting treatment, disorder of intestine microbiota, et al are dilemma in clinical practice. Appropriate and formal diagnosis and treatment of ESLD combined infection are imperious nowadays.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antibiotics | This is an observation study, no specific antibiotics will be indicated during treatment |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2018-12-30
- Completion
- 2018-12-31
- First posted
- 2017-12-06
- Last updated
- 2018-09-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03363451. Inclusion in this directory is not an endorsement.